drugset / Trial / NCT01753102

Efficacy and Safety Of Spil's Estradiol Vaginal Tablet

NCT01753102

Phase 3 Terminated 49 enrolled Sun Pharmaceutical Industries, Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

Estradiol vaginal tablet is a tablet which hydrates upon contact with moisture, releasing 17ß-estradiol. The estradiol in estradiol vaginal tablet is chemically and biologically identical to the endogenous human estradiol and is therefore classified as a human estrogen. The purpose of this study is to demonstrate clinical endpoint bioequivalence of SPIL's Estradiol vaginal tablet, 10mcg estradiol to the reference listed drug (Vagifem®)which is approved and marketed in the US.

Timeline

Start
2012-11-06
Primary completion
2013-04-30
Completion
2013-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 10 ug Other

Indications